A PYMNTS Company

US: Abbott sets sights on expansion yet again

By  |  October 29, 2014

US-based pharmaceutical giant Abbott is reportedly planning its latest acquisition, this time with Topera.

Reports say Abbott is seeking expansion through acquiring the medical device manufacturer; reports say the deal was inked for $250 million.

Abbott, like other pharmaceutical conglomerates across the globe, has lately looked to acquisitions to expand its reach. The company additionally announce that it has received regulatory approval to acquire Advanced Cardiac Therapeutics; financial details of this deal were not disclosed by the companies.

Abbott’s takeover of Topera will need to gain regulatory clearance before it moves forward.

Full content: MarketWatch

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.